Marijuana is about to be taken off of Schedule I of the Controlled Substances Act...Please Read Again... http://www.alternet.org/drugs/federal-court-ruling-marijuana-proper-classification-delayed

OLD TYMER~ Second Green Rush~ April 15ish
http://www.alternet.org/drugs/federal-court-ruling-marijuana-proper-classification-delayed

Happy holidays everyone!

It's been an amazing year and we have accomplished a lot. I get exhausted just thinking back over everything we have done in 2014 and the pace at which we worked.

Looking back we've hit a ton of milestones this year; we put our greenhouse in operation and picked up some key customers like Walmart, Krogers and more.

We built an extraction facility in Oakland, we launched IVXX and are bringing one of the first brands of cannabis to the market. Our company has been featured on Fox, CNBC, Huffpo and about every other major media outlet in the country. We are very proud of what we have accomplished.

Our success, particularly in Nevada, has made one thing very certain, we have our work cut out for us in 2015. We are truly thankful to our shareholders, supporters, business partners and everyone who worked hard to make Terra Tech what it is today.

We wish the best to you and those that you care about and we wish us all the absolute best for 2015.

Derek

Intent to form Subsidiary:

"As previously announced, management of Green Cures would like to reaffirm their interest of expanding their services and operations within the hemp and cannabis industry, as permitted by law. The company continues to explore both, domestically and internationally the possibility of being able to supply raw materials for its current and upcoming products. "Green Cures will provide additional information about the company's first subsidiary, as soon as material events become available".

Agreed, the company's first subsidiary is a Game Changer!
A Blessed Christmas GURU shareholders...2015 is our Year!

Which leads to my other piece of advice.

Be patient. The great fortunes are made by taking a position and being patient, not by trying to time every step of the way. Forget about that. You cannot time success. It doesn't work. You pick your goals and you stick to them and in investing that means finding the right stock and committing. Keep doing your research while you hold, but realize BUSINESS TAKES TIME. Real business, not fantasy business like we see everyday being PR'd in penny stock land, takes time to mature.

Every success story is both simple and complex. The simple reason is the one you invest in - the story has focus, the plan has a target and the goal is understood by all: shareholders, management, consumers, vendors, clients, everyone understands the business plan. And it is complex because the world is complex and there are always another set of details around every corner that need to be attended to.

Successful companies do not pump themselves too far ahead of their ability to achieve their stated objectives. They say what their goals are and then set out to achieve them. It is really the shareholders who get all bent out of shape trying to time the developments, not the company itself. If something is going to happen in 1 month or 3 months, that is not necessarily something the company will divulge. Sometimes the best or the only prudent thing to do is to state the objective and leave the time frames open.

I believe to succeed often means picking the right company and banking on the management and their business plan and not trying to time every little thing. What week the products are released or the OTC listing is really not the point at all. Sometimes you need to pay attention to obvious clues and a big one is there are people who are accumulating, placing their bets and who are not trying to time every little detail.

Many of those longs who probably have large positions have no intention of settling for a mere double, but are looking to get rich, maybe retire and some are doing it for the first time in earnest instead of chasing momo stocks in the hope of finally leaving behind their day job. Whether or not GRCU is going to be that stock, at some point in your investing career you need to load up on something and ride it well if it does turn out to be a real winner.

That's my take on how to get rich and why GRCU might be one of those. We can't conclude it is yet, but we have some real inklings of what might happen and I'd say our odds of doing it here and of achieving multiples in the tens or hundreds of times our original investment costs are better here than most anything else I see out there right now.

That is why I say you should not be too focused on how quickly any one development will hit. Usually the bigger stories percolate along for a while and then the dam breaks open, both for the company and for the stock. One month you could be losing patience and the next month the dam could breaking and the stock soaring. If you really believe the stock is for you, any stock, this or any other that really convinces you of its potential for major gains, then don't get lost in worry and find yourself on the outside looking in just when things really heat up. You need to be in it to win it.

With all that said, I'm perfectly happy with slow and steady for the coming weeks and I seriously doubt we will go without solid developments in September and every month thereafter. Just get into your loaded boat and let the tide rise and the water come to you. Don't be hunting for a vessel when the flood comes because by then it will be too late to build a position so cheaply and profitably as you would be able to now and in the coming weeks.

All the best

Some advice if I may ...

I'm very pleased with the way everything is progressing with the company, with the stock and with the obvious growth of strong hands getting on board for the longer term implications of what GRCU can mean to us as investors.

All of the big gains I have ever made took me months to make, but those gains absolutely dwarfed what I would have otherwise made by trading. Picking the right stock and sitting on my hands remains my consistent winning strategy. It allows me to take larger positions than a trading position and that equals greater wealth making opportunities for me.

GRCU is one of those stocks in my opinion. Pick the one you have confidence in, buy more than you would for a trade and hunker down. It pays off much bigger and when you pick right and learn how to ride a winner that is how you separate the men from the boys and the women from the girls. If you don't discover that kind of company, don't do it. But if you do, take a stand for once and don't get all muddled by momo gangs, either by chasing them in various stocks or by letting them rattle you when they come in and out of your strong position.

The Conviction To Hold

Apostle, we found another Gem! Enjoy the Ride bro!

Extraordinary returns follow extraordinary discipline. Discipline in buying and selling, and maybe the most important one of all, holding. Developing the conviction to hold is something that I’ve learned over time. It didn’t come easy. The basis of this post is to give some insight on how to develop the conviction to hold your winners. It is very tempting to sell along the way, and it’s okay to take a little off the table, but the big money is made by holding.

“It never was my thinking that made the big money for me. It always was my sitting.” Reminiscences of a Stock Operator
Don’t bother finding the next multi-bagger if you aren’t going to develop the conviction to hold it

From my experience, the only way to hold onto a big position after it makes a big move is to know the underlying company better than anyone else. Greed and fear will test your resolve, so you need to learn to keep these emotions in check. You need to believe in your due diligence and form an unwavering conviction.

So how do you develop the conviction to hold?
A lot of due diligence is on the front-end of a buying decision, but it certainly doesn’t stop there. The maintenance due diligence following the buy decision is even more important. For me, I talk to management regularly and keep close watch of all the ancillary forces and trends that are driving the company’s business. My “edge” is knowing my positions better than anyone else. This doesn’t mean I’m going to be right, but the more I know the better.
I think many misperceive high conviction for close-mindedness, ignorance, and arrogance. The conviction I’m talking about is quite the opposite. You need to constantly assess your positions and openly listen to counter arguments. Only then will you have the conviction to hold multi-baggers because you will understand all sides to the story. You also need to develop a thick skin. If you are not ready to be criticized for your convictions than you aren’t ready to make real money.

In many cases the stocks I’ve owned were better buys after they doubled then when I initially bought them. In many cases when a position became 30% of my portfolio there was a reason for it. The underlying business was doing really well, or institutions were just starting to nibble on shares, so why would I sell it. Just because a stock doubles, triples, etc, doesn’t mean it should be sold. Stocks should be sold when your maintenance due diligence shows something has changed. If you know the story better than anyone, you’ll likely get clues well before the rest of the market. When a company performs, and the story hasn’t changed, stop trying to change it. Enjoy the ride.

When a stock goes on a multi-year run there will be long periods of time when nothing happens. These are consolidation periods when old shareholders are selling and new investors are buying in.

A big part of successful investing is becoming content doing nothing. If you are in great companies, a lot of times your biggest risk is boredom. Warren Buffett’s famous quote, “Our favorite holding period is forever”. Learn to be content holding and doing nothing.

A multi-year run is made up of a bunch of mini-cycles that can last weeks or months. During these times the stock can become undervalued or overvalued. Quite a few professional investors I know like to trade 10-20% of their full position during these swings. For my psyche I’ve found it to be counter productive. I’m fine simply holding it through the mini-cycles.

I hope I’ve helped shed some light on a hard but lucrative topic. Many investors spend all their time trying to find great companies only to sell them after quick paltry gains. If management is executing and the story hasn’t changed, hold on for the real money. Find great companies, develop the conviction to hold them, and it will change your life…
(written by a good friend & investor...Long GRCU

Great Post Onpoint2 (420,000)
Have you read about Pot paradise~Uraguay's call for bids from cannabis growers!!!


Pot paradise: Uruguay calls for bids from cannabis growers

Uruguay’s authorities have called on private pot growers to send in applications if they want to farm the plant in a government-run field as the country is taking a step closer to selling recreational drug.

The tender was issued from the Institute for the Regulation and Control of Cannabis (IRCCA), a newly formed governmental body which oversees the marketplace for marijuana. Open until August 18, it seeks up to five cannabis farmers who will get a license allowing them to grow the plant at a government-run field.

Five-year licenses will allow the growers to produce and distribute between one and two tons of pot a year. The drug will be allowed to be sold to the country’s pharmacies at about $1 a gram. The plant will then be sold to private owners with regulated sales to start early next year. The government expects some 150,000 people to sign up for the program, with annual production of around 20 tons of cannabis.

The area permitted for cannabis cultivation is in the southwest of Uruguay. The perimeter of the field will be guarded 24 hours a day, officials said.

The South American nation of Uruguay became the first country in the world to legalize the sale, cultivation, and distribution of cannabis in December 2013, despite global criticism.

Each Uruguayan citizen will have an opportunity to grow up to six marijuana plants, the equivalent of 480 grams, but only for personal use. The growers, on the other hand, will be allowed to produce and distribute a total of one to two tons of cannabis per year, to be sold at pharmacies for about $1 a gram.
According to the legislation, buyers will be able to grow their own or purchase cannabis via consumers’ clubs. The customers must be 18 or older, residents of Uruguay, and must be registered as cannabis consumers with the authorities.

Cannabis users will also be allowed to organize smoking clubs of 15 to 45 members, which will be able to grow up to 99 plants per year.

Congressman Perry introduces medical hemp act

Currently, more than 300,000 children in American suffer from some form of epilepsy. Many of these children experience more than 100 violent seizures a day— any one of which could be fatal without proper care. U.S. Representative Scott Perry introduces legislation today, the “Charlotte’s Web Medical Hemp Act of 2014”, to ensure that children and individuals with epilepsy and other debilitating seizure disorders have access to life-changing Cannabidiol (CBD) Oil and therapeutic hemp. There is anecdotal evidence that CBD oil has been shown to reduce the amount and duration of seizures in children suffering from epilepsy and other seizure disorders. This legislation would enable individuals access to this potentially life-saving supplement without having to split up families geographically in order to receive treatment.

“Earlier this year I was approached by three local families whose children suffer from severe epilepsy”, said Rep. Perry. “As a father, I can’t imagine how helpless and crestfallen I’d feel to be essentially out of options, without any significant way to help my child; and these families live with this circumstance every single day. Their heartbreaking situations compelled me to act at the federal level to enable their access to a supplement that literally has changed lives – not only in the form of relief for the individual who suffers from this condition, but subsequently for their families and loved ones as well. Unfortunately, this plant and its derivatives and extracts are currently banned for medical use at the federal level and are unavailable to the citizens of Pennsylvania; this legislation would remedy that.

This bill in no way changes my stance on marijuana—I still disagree with the recreational use of marijuana; however, these children and individuals like them deserve a chance to lead a healthy and productive life and our government shouldn’t stand in the way.”
“We applaud Congressman Perry and his leadership in creating access to this treatment for Americans with epilepsy who have run out of options,” said Philip M. Gattone, M.Ed., President & CEO of the Epilepsy Foundation. “As a parent of a child with epilepsy, I know how difficult it can be to stand by as your child has a seizure that you are helpless to stop. The Epilepsy Foundation has supported access to CBD oil – which is showing dramatic results for some patients. Access to a lifesaving treatment should not be determined or limited by zip code. It is time for Congress to enact this sensible bill that could help save lives.”
This legislation in no way federally legalizes the recreational use of marijuana, nor is CBD marijuana; rather, the bill is an incremental approach to providing relief to those suffering from ailments that could benefit from CBD oil and therapeutic hemp. It also doesn’t legalize all forms of marijuana for medical use. It removes CBD oil and therapeutic hemp from the federal definition of marijuana in the Controlled Substances Act. Therapeutic hemp is defined as having no more than .3% THC, which means it has no hallucinogenic effects of traditional marijuana.

The legislation now moves to the House Energy and Commerce and Judiciary Committees. If it is voted out of committee, it then moves to the full House for consideration.

Read more: http://fox43.com/2014/07/28/congressman-perry-introduces-medical-hemp-act/#ixzz38nIe4gAN

Banker Stocks,Thanks for your post.
Don’t invest where the big money is, invest where it is going to go!

Historical Short History of GRCU

http://otcshortreport.com/index.php?index=GRCU#.U5nBrXbztKI

Full Report/Green Cures & Botanical Distribution, Inc.

Green Cures announced the addition of CBD Capsules to its line of products to debut in the upcoming weeks. Green Cures’ set of 30 CBD Capsules will initially contain 50 milligrams of Pure CBD-Hemp Oil per capsule. Green Cures’ CBD Capsules do not contain controlled substances, as their low THC content falls within federal guidelines. Therefore, Green Cures will be able to market, distribute and sell its upcoming product online and through retailers across the nation. Cannabidiol (CBD) has been the subject of numerous scientific studies at several academic research centers in the United States and across the globe. It is the second most prominent ingredient found in the Cannabis plant, accounting for up to 40% of the plant’s extract. According to published scientific and clinical studies, CBD may act in the form of an experimental model to improve a wide range of conditions, including epilepsy, arthritis, rheumatoid, diabetes, alcoholism, chronic pain, schizophrenia, antibiotic-resistant infections, and other neurological disorders.

Green Cures is exploring additional opportunities to expand its services and operations within the hemp and cannabis industry, particularly, in the field of agriculture. “Currently, in the United States, the demand for high quality raw material throughout the hemp industry and cannabis medicinal field outstrips the supply; therefore, we are exploring the possibility of being able to supply raw materials for our current and upcoming products, domestically and internationally,” said Green Cures CEO Robert Calkin. At the present time, Green Cures plans to form its first subsidiary company, which will operate in the field of agriculture, as permitted by law. Furthermore, Green Cures is reviewing and has been in negotiations with several highly qualified individuals in the fields of horticulture and microbiology, with a view to their potentially joining the new subsidiary in the near future.
Green Cures is also pleased to announce that it has received an exclusive invitation to be part of the “International Cannabis Association” exposition scheduled for June 22, 2014, in Las Vegas, Nevada, where Green Cures will proudly showcase its current and upcoming line of products and services available to the public, as of the date of that event.

In an unprecedented 219-189 floor vote last week, the House of Representatives approved the end of funding for Department of Justice (DOJ) enforcement in medical marijuana states. Advocates are hailing the vote as a major victory that signals a shift in the approach Congress is taking on this issue. The vote was on Amendment No. 25 to the Commerce, Justice & Science (CJS) appropriations bill. One hundred seventy Democrats and 49 Republicans voted in favor of the amendment.

Marijuana banking scheme passes first test in Colorado legislature
1:11am EDT

By Keith Coffman

DENVER (Reuters) - Colorado lawmakers on Friday passed a bill that if enacted would lead to the first marijuana financial system in the United States, potentially granting legal cannabis businesses access to the Federal Reserve's money transaction system.

Traditional banks have been wary to knowingly serve legal and medicinal marijuana businesses because the drug remains illegal under federal law, said the bill's sponsor, Representative Jonathan Singer.

The cash-only nature of marijuana businesses is making them targets for crime, limiting access to capital, and impeding the state's ability to track revenues, Singer said.

"This sets up a new type of financial structure to the gap we're seeing between banking and the marijuana industry," said Singer, a Democrat.

The proposal calls for new "cannabis credit co-ops" - similar to credit unions without deposit insurance - to be governed by the state's financial services commissioner. But they would need Fed approval for access to banking services, such as credit card processing and checking accounts.

Voters in Colorado and Washington state passed statewide ballot measures in 2012 legalizing the possession and use of recreational pot by adults. Both states are among 20 that allow the use of marijuana for medical purposes.

In January, the first recreational retail shops opened in Colorado, and Washington is set to follow suit this year.

The Obama administration in February issued new law-enforcement guidelines aimed at encouraging banks to start doing business with state-licensed marijuana suppliers, like those in Colorado, even though such enterprises remain illegal under federal law.

On Tuesday, Treasury Secretary Jack Lew insisted in testimony before lawmakers that it was not tacit approval under federal law.

The Colorado measure passed on Friday on a preliminary vote and will be formally voted on next week. It needs approval by the state Senate and Governor John Hickenlooper to become law.

The banking cooperatives would not be traditional credit unions or banks because deposit insurance would not be required under the measure.

Many have expressed doubts that the Federal Reserve, which requires credit unions and banks to have insurance, would sign off on the plan.

(Editing by Robert Birsel)

$CWIR- FuzznBuzz Brands Inc. Notes, Facts, Info
Banker Stocks

* CWIR - Management sent a symbol change request with their filings to Finra back in early March. They should be getting a new symbol shortly to reflect new company business and or name.


1- Evidence in Business Change

http://www.otcmarkets.com/stock/CWIR/company-info

Business Description

Central Wireless is in the position of restructuring its business and operations to engage in the business of growing, packaging, and dispensing cannabis, cannabis food products, and cannabis beverages in those states where such activities are lawfully permitted. The company's senior executive management expects this restructuring to be complete by March 31, 2014.


Profile Data

SIC - Industry Classification 2833 - Medicinal and botanicals
-----------------------------------------------------------------------------------

FUZZnBUZZ Brands, Inc. - NAME CHANGE/FILING COMPLETE to reside COLORADO.

Fuzz n Buzz was a comic strip/cartoon in the 1980's that centered around the funny side of weed. The two main characters were obviously Fuzz the roach and Buzz the fly. Hence, the new name FuzznBuzz Brands Inc. Additionally, it looks like they have purchased the trademarks and will be using them to brand some of their products and i think alot more imo.

Michael Grande ?@mikegrandeCWIR 16h
finelineproperties.us / FuzznBuzz are gone from line up! pic.twitter.com/QPhRhjtaJs


https://twitter.com/mikegrandeCWIR/status/452280857533747202/photo/1
http://www.sos.state.co.us/biz/ViewImage.do?fileId=20141225689&masterFileId=20141225689&org.apache.struts.taglib.html.TOKEN=8b8742526706695e1776e16ce79d480f

TASTEEHIT.COM
http://who.godaddy.com/whoisstd.aspx?domain=tasteehit.com&prog_id=GoDaddy&k=flp7bK9Egnpgm8jS49jR3V64vR0gmWzcknjtK17vQb5tQs0PQ9zBDOIIJCN+bCL%2f

FUZZNBUZZ.com (plus, net, org, us, info extensions purchased)
http://whois.domaintools.com/fuzznbuzz.com
_____________________________________________________________________________________

2- Verified Emails and My Emails from company:

Thank you for your inquiry.

Central Wireless commenced its formal restructuring and reorganization the day before yesterday. Clearly, there are many facets of the repositioning that we must address not only to shareholders, but to regulatory and self-regulatory agencies. Consequently, I am limited as to what news I am able to release. I am able to state the company is being repositioned to engage in the cannabis industry; that negotiations have been ongoing with a number of parties, respectively, to position the company to engage in this business (under the laws of the respective states where such activities are legally permissible); that the company will be changing its name and has established a new website (although not published) to reflect these changes; and, to complete its formal reorganization in accordance with the notification that is being submitted to FINRA not later than tomorrow.

Thank you for your continuing interest in Central Wireless and in The Hudson and Grande Organization.

Best regards,
Randy Hudson

ec: Michael P. Grande
---------------------------------------------------------------

Thank you for your inquiry and interest in Central Wireless.

First Hudson Trust and EMS own 67% of Central Wireless and have owned such shares since February 1, 2014.
Central, under the direction of its President, Mike Grande, has been in discussion for the past month to manufacture and place the company's products, initially, in California and Colorado. Of course, the company's primary business will be the manufacture, packaging, and dispensement of cannabis and cannabis-related products, candies, foodstuffs, e-cigarettes, and, through one or more of its affiliates, THC-based beverages.

All of this news will be released following the company's restructuring, which will begin on 11 March and take about three weeks.

The company's new website will be up and running at about the same time.

Thank you for your continuing interest in Central Wireless Inc. and in The Hudson and Grande Organization.
Best regards,
/s/ Randy Hudson
------------------------------------------------------------------

3- Tweets by CEO- This account is 100% verified Mr. Grande.

https://twitter.com/mikegrandeCWIR

Michael Grande ?@mikegrandeCWIR Mar 30
Make no mistake! CWIR is our Baby! And i'll DEFEND her!

Michael Grande ?@mikegrandeCWIR Apr 2
Don't listen to anything Randolph or I do not put out!!! Too many Dog & Pony shows!!! News is coming! We are not in the PR biz!!!

Michael Grande ?@mikegrandeCWIR Apr 4
If all these CEO"s are so busy building stock price? Who is building a company?Negotiating premium staff,Products? services? Relationships?

Michael Grande ?@mikegrandeCWIR Apr 5
No Preferred conversion! 5 B total Authorized! End of story! Let's build our brand...

Michael Grande ?@mikegrandeCWIR 16h
finelineproperties.us / FuzznBuzz are gone from line up! pic.twitter.com/QPhRhjtaJs

4- Emails and Facts on Current Share Structure

Notes from email:

I asked him several questions cause we there were so many different share structure numbers and transfer agents it got really confusing to me. So, below you will see the A/S will be restructured to 5 Billion for the new company in CWIR which is down from 20B in which Pacific Stock is reporting.(YEAH!!!) Secondly, he did confirm that they common unrestricted stock OS was a the number below, and restricted was correct also. Thirdly, THERE WILL BE NO REVERSE STOCK SPLIT OF CWIR.(This is GREAT NEWS FOR CWIR LONGS!) Also, Central is getting a name change to coincide with the new business that its in and they filed for a new trading symbol as well. Finally, but actually stated it first that everything is on track from the the target date of 3 weeks from March 11 which would be April 1, I believe. However, from a previous email we are realistically looking at March 31 to sometime the 1st week or April.

I'm really exciting guys being a long in CWIR. These guys mean business and its not just another mj/cannabis pop up company scam like a lot of them. They will have a major presence in mj/cannabis with many different products that will be introduced over time. This is NOT going to be a silly 1 product or website company, we are talking a major presence in this sector. I was told to refer to this link: http://www.otcmarkets.com/stock/CWIR/company-info

Authorized #: 20,000,000,000 ---> will be restructured to 5B
Outstanding #: 1,954,192,451 ---> is correct
Restricted #: 867,242,559 ---> is correct

Float: Is relatively small. Stock is very sensitive to ops trades up and down. It could be as low as 500M or less to 1B. Not sure, but look at the chart and volume and moves compared to other stocks.
-----------------------------------------------------

Following Central's restructuring, Central will be authorized to issue 5 Billion Shares. It will also have a new name, which is trademarked, and that will coincide with its domain name. At this point in time, the company's board of directors have determined that there will be NO reversal of the company's stock. The company is requesting a new symbol to further coincide with its name change; although, we won't know if our symbol request will be granted until FINRA completes its review of our notifications and request, which could be 12 business days from today or longer. Moreover, the company is in the process of engaging a new stock transfer agent. The appointment should be completed sometime next week.

For further information, please await the company's announcements.

Best regards,

Randy Hudson
ec: Michael P. Grande
Kenneth W. Brand
----------------------------------------------------------------------

FROM CEO THIS MORNING ON TWITTER: I will listen to mr hudson the ceo, and he as stated as early as this morning the following:

Michael Grande ?@mikegrandeCWIR 2h
No Preferred conversion! 5 B total Authorized! End of story! Let's build our brand...
Expand

So, The CEO just told everyone in a public forum: No preferred conversion, and NO issuing of shares from Authorized- They want to build the brand and not interested in selling shares or submitting fluff prs to sell shares..

and via email i posted that:

From Mr. Hudson directly as well:

Due to certain determinations made by Central's senior executive management, there will be no reverse split of Central's stock at this time.

We are in the process of changing the company's stock transfer agent, as Florida Atlantic Stock Transfer went out of business and its successor was terminated on 19 March.

Following the restructuring, the company will have 5 Billion shares authorized; however, we don't plan on any issuing new shares beyond those in our private placement (as we previously mentioned) and under stock incentive plans for our senior executive-grade officers.

Thank you for your continued interest in Central Wireless, Inc.

Best regards,
Randy Hudson

_________________________________________________________________________________

5- Misc. Notes

When CWIR hits the official MJ sector list, it will rocket up an attract 1000X more eyes and radars. That can happen any day now as per all the dd we have on otcmarkets.com, emails from CEO, etc. We are below ground floor prices here. Lock them up, accumulation by longs here until official is definitely beginning to show. Float is small as well, a lot less than many MJ stocks .10 and above. It is one of the thinnest and most undervalued MJ stock out there, but once officially OFFICIAL that will change rapidly. Finally, there are MJ stocks with billions upon billions in the float that trade over .10 cents and more, this will be very hot MJ sector stock very soon. Some MJ stocks with similar floats trade as high as .50+

---------------------------------------------------------------------------
CWIR will be the MJ/Canabis business under Hudson and Grande Management. This is 100% accurate and a FACT. They will be an affiliate of their other companies by virtue of management only and some lease transaction from National Properties Trust.

----------------------------------------------------------------------
Other MJ FLOAT comps vs. CWIR-->

CWIR float is about 600M imo:

MJ stocks with OS and FLOATS off otcmarkets.com: Chance are these floats are even higher now from these stock below cause most of them are diluting. A lot of the stocks get 100's Million vol. daily and CWIR gets about 20M on the avg. Imagine when they starting putting official MJ announcements out and clean up OTC markets, New company name and ticker.


ERB*-.0835
ERB* Security Details
Share Structure
Market Value1 $290,219,029 a/o Mar 28, 2014
Shares Outstanding 3,475,676,996 a/o Dec 13, 2013
Float 3,191,885,389 a/o Dec 31, 2013
Authorized Shares 4,750,000,000 a/o Jan 13, 2014


MIN*-.0335
MIN* Security Details
Share Structure
Market Value1 $70,924,194 a/o Mar 28, 2014
Shares Outstanding 2,117,140,128 a/o Mar 20, 2014
Float 1,489,000,000 a/o Jan 01, 2014
Authorized Shares 2,500,000,000 a/o Apr 24, 2013
Par Value

MYE* .0665
MYE* Security Details
Share Structure
Market Value1 $205,240,379 a/o Mar 28, 2014
Shares Outstanding 3,086,321,486 a/o Feb 07, 2014
Float 1,032,648,198 a/o Feb 07, 2014
Authorized Shares 4,900,000,000 a/o Sep 30, 2013
Par Value 0.001


TTD* .035
TTD* Security Details
Share Structure
Market Value1 $37,315,086 a/o Mar 28, 2014
Shares Outstanding 1,743,695,597 a/o Sep 30, 2013
Float 1,531,010,602 a/o Sep 30, 2013
Authorized Shares 2,000,000,000 a/o Sep 30, 201

FITX* .0842
FIT* Security Details
Share Structure
Market Value1 $286,782,636 a/o Mar 28, 2014
Shares Outstanding 3,405,969,548 a/o Mar 21, 2014
Float 2,295,374,724 a/o Mar 21, 2014
Authorized Shares 3,500,000,000 a/o Mar 21, 2014
Par Value

HEM* .101
HEM* Security Details
Share Structure
Market Value1 $166,644,888 a/o Mar 28, 2014
Shares Outstanding 1,649,949,387 a/o Sep 30, 2013
Float Not Available Rumored over 1M
Authorized Shares 3,000,000,000 a/o Sep 30, 2013


MJN* .26
MJN* Security Details
Share Structure
Market Value1 $248,509,086 a/o Mar 28, 2014
Shares Outstanding 948,507,961 a/o Dec 31, 2013
Float 411,045,323 a/o Mar 31, 2013
Authorized Shares 950,000,000
-----------------------------------------------------------------

The FLOAT is tiny, look @ the volume and chart and the % gains. A/S means nada, we actually thought it was 20B but Hudson and Grande restructured to 5B, they could have very easily made it 20B but they didn't. Anyone watching this trade knows its super thin and moves up very very fast. Look at the chart, and the micro volume and its large swings.
---------------------------------------------------------
We are still in the infancy here in CWIR, IT HAS REALLY NOT EVEN STARTED YET. Heck we just got the company name change filing on 3/5/14 and we are awaiting the new trading symbol. WE still have NOT had their OFFICIAL ANNOUCEMENT OR STATEMENT via the wires on their entrance into the MJ/Cannabis sector and their plans, so many still view this as rumor. ITS GOING TO GET REAL INTERESTING IN THE DAYS AHEAD.

CWIR NOTES and INFO:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=100122340

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=100348778

The Rosen Law Firm Announces Investigation of Securities Claims Against GrowLife, Inc.

[Business Wire] - The Rosen Law Firm announces that it is investigating potential securities fraud claims against GrowLife, Inc. resulting from allegations that the Company may have iss
2:23 pm Growlife responds to SEC notification; says 'we will fully comply with the SEC's requests for information, and continue business as normal during this temporary suspension' (shares halted)
GrowLife Response to SEC Notification

[PR Newswire] - WOODLAND HILLS, Calif., April 10, 2014 /PRNewswire/ -- GrowLife, Inc. (OTCBB: PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services ...

PHOT Three Steps Forward, Two Steps Back~

Disclosure Of Seeking Alpha's Author Dazed And Confused By Growlife - Shares Are Worth A Small Fraction Of Their Current Price

ABOUT
I am a long/short investor with 20 years of investment experience as an analyst/PM at various mutual funds and hedge funds in the US. I conduct in-depth bottoms-up fundamental research across various sectors.

See Seeking Alpha's policy on anonymous authors.
SNAPSHOT

Description: Hedge Fund Manager.
Interests: Stocks - long, Stocks - short

420 Investor Alan Brochstein: United States Has Led A Failed War On Drugs By Jason Shubnell

Richard Nixon declared it public enemy number one.

The Reagan administration told citizens to 'just say no.' But among the long-running 'war' on drugs, reality has risen to the top, particularly when it comes to marijuana.

Still, even the president keeps his words slightly guarded when it comes to the plant.

"It's hard to admit when you're wrong," Alan Brochstein told Benzinga. "They have to have a graceful exit (from the war on drugs). Just think about how long it took to get out of Vietnam."

Brochstein, known to many as the 420 Investor, spoke to Benzinga on several issues within the marijuana industry. He said there is still room for the advancement of medical marijuana and its potential benefits (or lack thereof), but since it is federally illegal, research is limited. He is not the first to say the 'war' has been a failure, nor will he be the last.

"There's 70 or more cannabinoids and other parts of marijuana. Some say you need the whole plant..or just certain strains. It gets tricky," said Brochstein. A study by Dr. Sanjay Gupta cited that there are actually 66 cannabinoids among the 480 natural components of a marijuana plant, noting that "all [of] these components of the cannabis plant likely exert some therapeutic effect, more than any single compound alone."

Among the most prominent are THCs (tetrahydrocannabinol) and CBDs (cannabidiol). THC is the psychoactive competent that helps get a consumer "high"; however, this can also help alleviate certain pains and increase a person's appetite. CBDs, in their pure form, can treat certain illnesses, but without the lingering "high" effect. One report has shown that even just one drop of a CBD-based oil can help prevent seizures and other problems associated with epilepsy.

I think the attitudes are already starting to reverse in the medical community even if docs won't discuss openly.
— Dr. Sanjay Gupta (@drsanjaygupta) March 12, 2014

Brochstein said it will be easier for the industry to continue its advancements once they have better-developed evidence of marijuana usage and effects, but there's still risk among the federal government. "My impression is that people were totally unaware of the medical benefits," said Brochstein. Even he was not aware of the benefits until a little over a year ago, when he was able to better research and educate himself on the subject.

GW Pharmaceuticals (OTC: GWPH), located in the U.K., has been the most prominent in this development, having reportedly spent the last decade and over $100 million into marijuana research. This help result in Sativex, a marijuana-based drug that has helped treat people with multiple sclerosis. Still, marijuana must be consumed in a smart way. Overindulgence, whether by accident or lack of education or accident, can lead to emergency room visits.

Moderation remains key, whether on war, drugs or anything in between.

This is the first in a series of pieces with comments from leading industry analyst and 420 Investor Alan Brochstein. Check back for his thoughts on marijuana business and investing

© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Grow Life GIFT

Currently, GrowLife (PHOT) is considering 10 to 20 other GIFT transactions with various legal cannabis related companies.

"It's a great way for cannabis companies and especially start ups to get into the industry," said Darrin C. Duber-Smith, marketing professor with Metropolitan State University in Denver. "It's simply smart marketing on the part of GrowLife because the state of Colorado is wide open to these alliances right now. It's also a good opportunity to make money at least in the short term and building goodwill in the industry isn't a bad idea either."

Go PHOT!!!

Dabs: The World’s Most Powerful and Sought After Weed Product

By Matt Harvey | May 15, 2013 - 11:00AM

Across the country, from legal 21-and-over Denver dispensaries to black-market NYC delivery services, steeply priced strains of “killer bud”—so thick with tricome crystals they shimmer like snow-covered pine trees—are readily available. OG Ghost Train Haze, Headband, Blue Dream, Lemon Diesel, and Kosher Kush (and dozens of other similarly named varieties), pick your poison. Containing levels of THC up to 25%, a small toke of any one of these varieties will get you stoned.

But for some herb connoisseurs (and medical users in some states) these killer strains are not nearly strong enough. Especially on the west coast and in Colorado, where high-grade pot is much more prevalent due to relaxed laws, a few hits of chronic is strictly to get out of bed on a busy morning. For all other occasions and mind states there’s “dabs,” a type of solidified hash oil also known as “concentrates,” BHO (Butane Hash Oil) or more popularly, “wax”—so-named for its texture and glassy appearance. While no one person has taken credit for developing its extraction formula, the substance first started to appear out west about five years ago, but has since experienced galloping popularity. (Traditional hash oil has been around since at least the early 1970s.)

Most commonly created by a technique in which high quality pot is blasted with butane that is then extracted, these cannabis concentrates approach 70%-to-90% THC. Going on the basis of such super high purity alone, even the funkiest colored tricone crystal encased high-grade leaf start to look like steam technology in a fossil fuel world. Brad Gibbs, of Greenest Green, which has just opened a new state-approved lab in Denver Co., filled with $100,000 in equipment, specializing in BHO, says that the new product is so superior, buds will eventually disappear, at least among, “our generation,”—users under 40. “Dabs are the future of cannabis, both recreational and medicinal,” he adds.


Kyle Tracey, CEO of GrowLife Inc., a publically-traded growing supplies company and himself an enthusiastic evangelist for cannabis’ palliative effects, breaks down the price differential between “top end flowers” and “concentrates” where he lives in Southern California as follows: $15-$20 per gram for buds versus $70-$100 for the same amount of dabs (weight wise, 1/2 (g) dabs on average, is equal in strength to 3.5 (g) of high end weed.) Due in no small part to the higher price of having to do business illegally, cannabis prices are significantly higher on the East Coast in general and “wax” has yet to be seen here on anything but a limited scale. But Tracey, originally from Monmouth County, NJ says as East Coast dealers learn to formulate the product, and begin to gauge its rampant appeal, that situation is bound to change. “You’ll be seeing it out there soon,” he adds.

While dabs are hot in California, ground zero of the new fad is Colorado, one of two states (along with Washington) where pot is legal for recreational as well as medical use. A couple of Saturdays ago, on April 20th, between 40,000 and 50,000 potheads converged on Denver, in the largest celebration of 4/20 of all time, creating a massive marketing opportunity for hundreds of cannabis purveyors. Tracey, who has a promotion deal with High Times, says just like that magazine “marketed a lifestyle around pot, companies can brand a lifestyle around dabs for the next 10-15 years.” In other words, there’s lots of money to be made.

But not so fast: dabbing isn’t the new lifestyle choice for you if a hit of chronic sends you fleeing underneath the covers with paranoia. “If you don’t like smoking pot, ‘concentrates’ definitely aren’t for you,” Tracey says, allowing that the trend has sparked controversy within what he calls “the one billion dollar legal marijuana industry.” On one side are those, like Tracey, who celebrate the sheer knock-you-on-your-ass highs of BHO (Butane Hash Oil,) and similarly formulated concentrates. The opposing faction contains bud traditionalists and those worried about the effects blowtorches and wax-like substances will have on the industries’ image.

This conflict was aired by, of course, High Times, in a story titled “To Dab or Not to Dab.” While mostly positive in keeping with the magazine’s avowed pro-cannabis theme, the piece shed light on the negative consequences that have popped up from the burgeoning dabs trend. Among incidents related to its production and use were untrained cooks “blowing themselves up” blasting butane in jury-rigged home labs, and “overdoses,” which as with strong marijuana are not fatal but involve extreme discomfort to the point of freaking out for long periods of time.

Scariest was the case of a young woman who was hospitalized from a near-fatal allergic reaction in which her throat closed up after smoking dabs. Then there is the potential public relations blowback against the still nascent industry, currently waging a state-by-state battle for wider legalization, when the super-high purity, butane, blowtorches and waxy concentrate invariably lead middle-class observers to think of crack and crystal meth.

Nikka T, himself Colorado-based and a celebrated manufacturer of concentrates, takes such PR concerns seriously enough to be wary of butane in general. His method foregoes “blasting” with blowtorches altogether, relying instead on a solvent-free mechanical extraction technique, which he has gradually perfected over a decade. T, who has a beard and wears his long, thick black hair in a ponytail, was raised around the pot farms of Northern California. He started selling weed in high school and recalls being exposed to the dirty, mildewy-smelling, putty-textured “bubble hash” found in his hometown. “I knew there was something more out there,” he says. “So I started to play around [with concentrates.]”

Then, 8 years ago, T made a pilgrimage to Amsterdam and sat at the knee of noted cannabis developer Mila Jansen, who passed down to him the recipes, which he says have been kept alive in Europe for “200 years” (most sources date the invention of hash oil back more recently) by an “oral tradition,” even as the product remained unknown in the states. Now, on average, his Denver lab, Essential Extracts, processes from two to five pounds of marijuana into concentrates a day. His product sells from between $20 to $50 a half gram at nearby dispensaries. (Prices in Colorado skew low because of a flood of competition of cannabis suppliers in that state.)

Tracey, who is 28 years old and prescribed cannabis for Crohn’s disease, a painful stomach ailment, under California’s medicinal cannabis law, describes his CEO job as “mostly R and D.” Having smoked cannabis since high school, Tracey switched to “wax” in earnest three years ago and hasn’t looked back towards the leaf since. With the possible exception of a few early morning tokes off a “snappy sativa to vacuum the house,” he’s otherwise “switched to dabs almost totally.” To that end, he’ll fortify himself throughout the day with nail-sized hits from a small vaporizer that resembles an e-cigarette. This delivery-system has a built in advantage to weed: near invisibility to law-enforcement.

“I don’t think there’s ever been a time I’ve ever taken it too far,” he adds.

Now 30, Nikka T, is more cautious with the powerful new cannabis formulas at his daily disposal. “After smoking concentrates for 8 years straight, it got too much. My tolerance got too high,” he says. So just as the concentrate fad started heating up among his consumer base, his personal preferences were moving in the opposite direction. “Now I produce concentrates for the masses and smoke flowers throughout the day,” he says. And dabs? They’re reserved exclusively for nighttime.

Ace, I like this part...Joint Venture (JV) with Vape Holdings, Inc. (otcqb:VAPE) to fund the research and development of patentable technology to create pharmaceutical grade extractions from cannabis.

Apostle, when shareholders are sitting on massive profits, a different kind of investor is employed. If you want the GOLD ya gotta hold...it took strong conviction & intestinal fortitude to sit on massive profits & stay the course for much much much more!!!!!GLTA...

NEW YORK (MainStreet) — The GrowLife Infrastructure Funding and Technology (GIFT) program completed its first transaction with L.E.A.F. Aspen, providing equipment to the Colorado medicinal pot dispensary in exchange for monthly payments.

"The program that we offer is for selective clients in certain states to accelerate growth in the legal cannabis industry," said Sterling Scott, CEO of GrowLife in Woodland Hills, Calif.. "Our objective with the program is to increase scale, market penetration, revenue and earnings for GrowLife."
Related Articles

Cannabis Shortage Combatted by GrowLife GIFT
Can Legalized Marijuana Justify Legalized Prostitution?
Marijuana Investment Warning: Don't Get Too High on Pot Stocks
Marijuana Mutual Funds Emerge Out of Hazy Legal Horizon
Medical Marijuana Stock And Beyond: Cara Therapeutics CEO Explains

Through GIFT, growers can acquire and pay for equipment over time.

"We expect these transactions to be in the range of $500,000 to $5 million but that will vary depending on the company and on the yearly terms of the arrangement, which can be from one to 5 years," Scott said.

GUPTA GAP UP tomorrow!!!

Yesss! Apostle, they are history brother!
PHOT on the fast lane to $.75

Dr. Sanjay Gupta ?@drsanjaygupta 13m
.@HempRep try this. http://cnn.it/1gn50DW

In Reply to 'HotStockAce' on 'GrowLife, Inc. (PHOT)'

I especially like this part...Go Phot!!!

Cannabis & Biotech Advancers Forging Ahead - Company Contracts With One of The Oldest Marijuana Dispensaries in California
9:05a ET March 10, 2014 (PR NewsWire)

Growlife, Inc. (OTCQB: PHOT) a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services of legal cannabis, is pleased to announce the completion of its first GIFT transaction with CMMS, Inc., known better in the Colorado mountain ski communities as LEAF Aspen and Fat City Test Kitchen. The GrowLife Infrastructure Funding and Technology program (GIFT) allows fully-licensed and compliant growers and dispensaries in well-regulated cannabis markets to spread the cost of infrastructure builds over time. The GIFT program is intended to facilitate near term infrastructure needs paired with long term exclusive supply relationships for the expendables required by fully licensed growers and dispensaries.

Gupta: 'I am doubling down' on medical marijuana
By Dr. Sanjay Gupta, CNN Chief Medical Correspondent
March 6, 2014 -- Updated 1340 GMT (2140 HKT)
Source: CNN
STORY HIGHLIGHTS

A growing number of patients want cannabis as a medicine
"It is irresponsible to not provide the best care we can,"
Sanjay Gupta says Those with influence are paying attention to the debate The public has become intensely engaged

Editor's note: Don't miss "Weed 2: Cannabis Madness: Dr. Sanjay Gupta Reports," at 10 p.m. ET on Tuesday. Also, Dr. Gupta will be answering your questions on Reddit at noon ET Tuesday.

(CNN) -- It's been eight months since I last wrote about medical marijuana, apologizing for having not dug deeply into the beneficial effects of this plant and for writing articles dismissing its potential. I apologized for my own role in previously misleading people, and I feel very badly that people have suffered for too long, unable to obtain the legitimate medicine that may have helped them.

I have been reminded that a true and productive scientific journey involves a willingness to let go of established notions and get at the truth, even if it is uncomfortable and even it means having to say "sorry."

It is not easy to apologize and take your lumps, but this was never about me.

This scientific journey is about a growing number of patients who want the cannabis plant as a genuine medicine, not to get high.
Dr. Sanjay Gupta is a practicing neurosurgeon and CNN\'s chief medical correspondent.
Dr. Sanjay Gupta is a practicing neurosurgeon and CNN's chief medical correspondent.

It is about emerging science that not only shows and proves what marijuana can do for the body but provides better insights into the mechanisms of marijuana in the brain, helping us better understand a plant whose benefits have been documented for thousands of years. This journey is also about a Draconian system where politics override science and patients are caught in the middle.

Since our documentary "Weed" aired in August, I have continued to travel the world, investigating and asking tough questions about marijuana.

I have met with hundreds of patients, dozens of scientists and the curious majority who simply want a deeper understanding of this ancient plant. I have sat in labs and personally analyzed the molecules in marijuana that have such potential but are also a source of intense controversy. I have seen those molecules turned into medicine that has quelled epilepsy in a child and pain in a grown adult. I've seen it help a woman at the peak of her life to overcome the ravages of multiple sclerosis.
Georgia House approves medical marijuana
Fla. to vote on medical marijuana
Can medical marijuana help seizures?

I am more convinced than ever that it is irresponsible to not provide the best care we can, care that often may involve marijuana.

I am not backing down on medical marijuana; I am doubling down.

I should add that, although I've taken some heat for my reporting on marijuana, it hasn't been as lonely a position as I expected. Legislators from several states have reached out to me, eager to inform their own positions and asking to show the documentary to their fellow lawmakers.

I've avoided any lobbying, but of course it is gratifying to know that people with influence are paying attention to the film. One place where lawmakers saw a long clip was Georgia, where the state House just passed a medical marijuana bill by a vote of 171-4. Before the legislative session started, most people didn't think this bill had a chance.

More remarkable, many doctors and scientists, worried about being ostracized for even discussing the potential of marijuana, called me confidentially to share their own stories of the drug and the benefit it has provided to their patients. I will honor my promise not to name them, but I hope this next documentary will enable a more open discussion and advance science in the process.

Marijuana is classified as a Schedule I substance, defined as "the most dangerous" drugs "with no currently accepted medical use."

Neither of those statements has ever been factual. Even many of the most ardent critics of medical marijuana don't agree with the Schedule I classification, knowing how it's impeded the ability to conduct needed research on the plant.

Even the head of the National Institute on Drug Abuse, Dr. Nora Volkow, seems to have softened her stance; she told me she believes we need to loosen restrictions for researchers.

Along the way, the public has become intensely engaged. Our collective society has paid closer attention to this issue than ever before, and with that increased education, support for medical marijuana has only grown, including in some unexpected places.

Pete Carroll, the coach of the Super Bowl-winning Seattle Seahawks, said the National Football League should explore medical marijuana if it helps players. NFL Commissioner Roger Goodell hasn't dismissed the idea, saying that if marijuana is reconsidered by the medical establishment, the league would treat it the same as any other medicine. Goodell also says the NFL is following the science that suggests marijuana may help recovery from concussions.

Recently, I had the chance to tell him that the United States already holds a patent on medical marijuana for that very purpose. Patent No. 6630507: Cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke or trauma.

However, this particular issue still bothers me: How can the government deny the benefits of medical marijuana even as it holds a patent for those very same benefits? Members of the Food and Drug Administration declined my repeated requests for an interview.

This past year, President Barack Obama told the New Yorker magazine, "I don't think (marijuana) is more dangerous than alcohol." And yet, as alcohol remains available to any adult, the president has not moved to remove marijuana from the list of the most tightly controlled substances in the country.

Since I started my reporting on this topic, I have mostly resisted temptation to inject a subjective moral equivalency into this discussion, such as pitting alcohol against marijuana or reminding you that cocaine and methamphetamine are actually more available than marijuana to patients, physicians and medical researchers: They are Schedule II drugs, with recognized medical uses. Or telling you that on average, a person dies every 19 minutes in this country from a legal prescription drug overdose, while it is virtually unheard-of to die from a marijuana overdose.

But, with a discussion like this, consistency does matter. Terms matter, too.

We are talking about a medicine, known scientifically as cannabis. In order for people to start thinking of this substance as a medicine, perhaps we should start calling it by its medical name, something that was suggested to me by medical marijuana advocates pretty much everywhere I went this year.

I've tried to pull together these latest developments in our new documentary, "Cannabis Madness." Although the 1936 film "Reefer Madness" was propaganda made to advance an agenda with dramatic falsehoods and hyperbole, I hope you will find "Cannabis Madness" an accurate reflection of what is happening today, injected with the best current science.

You will meet families all across the country -- a stay-at-home mom from Ohio, a nurse practitioner from Florida, an insurance salesman from Alabama -- more than 100 families who have all left jobs, homes, friends and family behind and moved to Colorado to get the medicine that relieves their suffering.

As things stand now, many of these good people don't ever get to return home. Why? Because transporting their medicine, even if it is a non-psychoactive cannabis oil, could get them arrested for drug trafficking. And so they are stuck, cannabis refugees.

You will meet them, and if you're like me, you'll be heartbroken to hear their stories, but you'll also have a lump in your throat when you see the raw, true love these parents have for their sick children.

History books may one day draw a parallel between this chapter of medical marijuana and the story of David and Goliath. Playing the role of David's slingshot, which ultimately brought Goliath to his knees, would be a 2-year-old girl named Vivian Wilson. She inspired her father to challenge the system in a spectacular way that caused a nation to stop for a moment and take note.

For months, we have filmed and followed the Wilson family with all of their trials and tribulations, and you will meet the whole family in the upcoming documentary.

I am a father myself, first and foremost. I don't want my children taking or being offered a psychoactive substance. As a neurosurgeon, I know that the developing brain is more susceptible to the most harmful effects of cannabis and that brain development continues well into our mid-20s.

I also worry that generations from now, my great-grandkids will find Internet headlines referring to me as the "pot doc." I do hope they will also read the rest of the story and understand the lives of the countless people who have suffered needlessly when a plant could have helped. I hope they know that I have dedicated my time to researching the medical literature, speaking to the scientists in person and piecing together a fact-based presentation meant to educate, not frighten.

I hope future generations won't consider me naive. Yes, I know there is a concern that many people out there will feign ailments just to get marijuana. But withholding legitimate treatment for the needy is a very unjust way of addressing that concern.

As a physician and reporter, I feel a deeper obligation to present the real stories, soundly supported with the science from all over the world.

When I first apologized for my previous marijuana reporting, I was thinking about the impact that reporting may have had on Charlotte Figi. She is a sweet little girl whose brain was locked in nearly nonstop seizure activity. Without success, she tried seven different medications, stringent diets and high-dose supplements. Modern medicine had nothing more to offer, which is why her parents turned to an ancient plant. As you know, it worked.

And, as you will see, she is one of so many patients out there, suffering from different ailments, who believe cannabis rescued them when nothing else did.

For conditions like Charlotte's, the American Epilepsy Society says that there are a million people for whom existing therapies do not control their seizures. The society recently said anecdotes about medical marijuana "give reason for hope" and said it supports "well-controlled studies that will lead to a better understanding of the disease and the development of safe and effective treatments."

You should know that Charlotte continues to do well. When I saw her around the holidays, she ran over and gave me a hug. She looked me in the eyes, took me by the hand and led me all around to meet her friends. She is a delightful, happy and now healthy little girl.

I know the discussion around this topic will no doubt get heated. I have felt that heat. But I feel a greater responsibility than ever to make sure those heated discussions are also well-informed by science.

And, with that: I hope you get a chance to watch on March 11 at 10 p.m. Eastern.

CNBC "Marijuana in America: Colorado Pot Rush" tonight at 10p ET/PT

Marijuana Stocks Surge on 1st Trading Day of New Year

Shares of public cannabis companies started off 2014 with a
bang, posting huge gains on the first day of trading since
the successful launch of the nation's first recreational
marijuana stores. Check out our roundup of stock
performance: http://mmjbusinessdaily.com/?p=18321

Our Briefs for You Today:

#1. Vermont Recreational Cannabis Bill Introduced

#2. Nevada on Track With MMJ, Officials Say

Contact CannaBusiness Media:

Editorial, Chris Walsh & Fred Dreier
Editorial@CannaBusinessMedia.com
Twitter @MJBizDaily
Facebook

Customer Service
CustomerService@CannaBusinessMedia.com
(401) 354-7555 x1

Sponsorships, Aimee Croke
AimeeC@CannaBusinessMedia.com

Publisher, Cassandra Farrington
CassandraF@CannaBusinessMedia.com

(c) 2013 CannaBusiness Media, a division of Anne Holland Ventures Inc.
Anne Holland Ventures Inc, 116 Summit Ave, Providence RI 02906

Summary

Management consultant with extensive technology experience and a history of growing companies. Marco has served as a Principal at The Chasm Group since 2006, as well as held several executive titles including President & CEO of private and public companies, Board chairman and director, finance and audit committee chair, vice-president of sales and marketing, senior director of product management, and began as a systems software engineer. He has led early-stage companies, grown small to mid-size technology companies, and set industry standards at market-leading corporations. Also, he has managed global programs and initiatives at Microsoft and Yahoo, and inventor of several patents.
Marco Hegyi, as New President

Over the last five years Marco has focused on business planning, operational management and financial supervision that has grown stealth start-ups. As a result, his contributions have led to over $140 million in equity financing from venture capital and private equity firms, strategic partners, and angel investors. His largest client accomplishment includes growing shareholder value from $10 million to $500 million, proof of concept with hundreds of million products, created competitive barriers by contributing to eight patent filings, recruited the management team, and delivered business and financial plans.

Before consulting, most of Marco’s experience was with eight companies, seven of which were market share leaders and the eighth was a leading challenger. At these market leaders he introduced de facto standards for network data management systems, defined cross-database integration systems, and PC-based monetization models. His sole-inventor patent at Microsoft used SaaS to manage the world's largest eco-system at one-tenth the cost and is extensively cited by Amazon, IBM and Accenture. His other accomplishments include smartphone pioneering, managing big data analytics for Yahoo, and establishing and managing overseas partnerships used to deliver highly complex services.

Dixie Sues MJN@
Download 37-2013-00058302-CU-BC-CTL_ROA-1_07-19-13_Complaint_1386643771884 - See more at: http://ab.typepad.com/the_daily_dab/download.html#sthash.RgXtsm5y.dpuf

CEO and President invited speakers providing more insight into our present and future!

"It has been an eventful period for our Company of late as we reported record quarterly revenue in excess of $1.3 million, introduced our dynamic new GIFT program, announced another new store opening, and debuted a new dispensary kiosk cash management system," stated Sterling Scott, CEO, GrowLife Inc. "We look forward to discussing all this and more during the show and providing more insight into our present and future."

GrowLife Debuts First Kiosk-Based Payment, Cash Management, and Regulatory Compliance Technology for Legal Cannabis Dispensaries
Live Model Debuted at National Marijuana Business Conference and Expo

PR Newswire
GrowLife, Inc. November 15, 2013 5:05 AM

GrowLife Debuts First Kiosk-Based Payment, Cash Management, and Regulatory Compliance Technology for Legal Cannabis Dispensaries

View gallery
GrowLife Kiosk for Legal Cannabis Dispensary transactions Click Here to Download Image

WOODLAND HILLS, Calif., Nov. 15, 2013 /PRNewswire/ -- GrowLife, Inc. (PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services addressing the needs of legal cannabis growing and retail operations, including hydroponic growing equipment and retail support software, is pleased to announce the successful debut of its proprietary kiosk-based retail software solution at the recent National Marijuana Business Conference and Expo in Auburn, Washington.

(Photo: http://photos.prnewswire.com/prnh/20131115/LA14118)

Through the GrowLife Financial brand, the software is installed on a dedicated kiosk providing not just a media rich point of sale experience for dispensary customers, but a cash and credit reporting system assuring tax and regulatory compliance for operators. Operating problems such as "cash shrinkage" and intense government focus primarily upon cash transactions are now addressed on a real-time basis allowing owners online access to detailed reporting tools.

"Our GrowLife Financial brand deploys into a new market segment for us: cannabis industry software development and electronic regulatory compliance. While we will continue to focus upon our core competency of hydroponic equipment and growing support, we now supplement these offerings with hardware and software tools geared specifically to the cash intensive regulatory environment of our customers," stated Sterling Scott, CEO, GrowLife Inc. "Recent developments in Washington and Colorado, as well as many other states, now mandate high levels of transaction security by management and geared to the specific regulatory setting unique to each location."

"Our kiosks provide dispensary customers with a user friendly product ordering system which then receives cash and credit payments," added Scott. "While we believe customers will greatly benefit from our built-in ease of use, we also believe that the 'stress level' of regulators looking to quickly assess dispensary sales activity is now also alleviated. We further confirm ongoing discussions with a number of 'seed-to-sale' cannabis software companies who have expressed interest in integrating their systems with our new product. We will continue to identify customer needs and distribute and develop products in response to these needs. We believe that our industry stands at the edge of monumental change and growth; GrowLife Financial is yet another way for our company to maintain our position at the forefront of these developments."

The GrowLife kiosk was included in a Fox news broadcast about the conference and industry. View here: http://bit.ly/1avdJ3n

For more information please visit: http://ezdispensarypay.com/

A GrowLife Investor Presentation can be viewed online at: http://growlifeinc.com/growlife-presentations-october-2013/

To view GrowLife's Cannabis.org Facebook page and TELL THE TRUTH movement please visit: https://www.facebook.com/tellthetruthfederalgovernment

About GrowLife, Inc.

GrowLife, Inc. (PHOT) (www.growlifeinc.com) develops, markets and deploys products and services addressing the needs of legal cannabis growing and retail operations, including hydroponic growing equipment and retail support software. The Company provides these solutions in our nationwide retail network, as well as online sites Greners.com, Phototron.com and RockyMountainHydro.com. The Company also operates the political and social forum, Cannabis.org

Cautionary Language Concerning Forward-Looking Statements

This release contains "forward-looking statements" that include information relating to future events and future financial and operating performance. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for GrowLife's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in GrowLife's filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include statements regarding future sales, costs and market acceptance of products as well as regulatory actions at the State or Federal level. For a more detailed description of the risk factors and uncertainties affecting GrowLife, Inc. please refer to the Company's Securities and Exchange Commission filings, which are available at www.sec.gov. GrowLife, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Company Contact:

GrowLife Inc.
Kyle Tracey, (800) 977-5255
kylet@growlifeinc.com

Investor Relations Contact:

Integrity Media
Kurt Divich (702) 396-1000
kurt@integrityir.com

short term speculation .136-.152+ BUT in 6-12 months .50-$1.00

Pot Pushback Goes Up in Smoke: $20 Billion Economy Awaits Marijuana Legalization By Nicole Goodkind | Daily Ticker

Approval ratings for marijuana are jumping. For the first time, a clear majority of Americans (58%) support legalizing pot, according to a recent Gallup poll.

“Marijuana Is a Vegetable” and Belongs in the Farmers’ Market: Pot VC

While it’s easy to joke about marijuana, it’s serious business. Annual marijuana sales (including illegal sales) add up to about $20 billion, according to Harvard economist Jeffrey Miron. Commercial medical marijuana sales now average around $1.5 billion a year and ancillary businesses surrounding the industry present a growth area that could easily make big money.

Troy Dayton, CEO of The ArcView Group, an advisory firm that connects dispensers and entrepreneurs in the cannabis industry, says the outlook for the secondary marijuana businesses is high. “Everybody from entrepreneurs who are just interested in the sector and want to put $25,000 to $50,000 to work, all the way up to billionaires and venture capital funds are looking to make investments.”

Stocks Poised For A Potential Breakout: Growlife Inc (OTCBB:PHOT), Renren Inc (NYSE:RENN)

Steven, you forgot to include the headline.
Best Regards...

Potential Catalyst To Drive Long-term Financial Results

During the second quarter, GrowLife reported revenues that increased 460% to $872,000 and year-to-date sales that soared to over $1.6 million. The company later announced that the Department of Justice’s September 2013 announcement led to record sales and transactional volume day on its Greners.com portal. Over the coming years, the firm plans to expand its retail locations to generate some $8 million in revenues this year and $15 million next year.

With a market capitalization of just $30 million, these revenues could send the stock sharply higher over the coming years, particularly as management moves the firm to breakeven. Many tobacco companies trade at a 2.5x to 4.0x price-sales ratio, which would equate to a $37.5 to $60 million market capitalization next year, or a 25% to 100% move higher in share price. And, these figures may be undervaluing the stock given its triple-digit growth rates.

The addition of Cannabis.org to the company’s coffers could dramatically enhance these revenues over the long-term. While the impact is difficult to quantify pre-launch, investors can view the move as just one of many catalysts that could drive shareholder value higher.

Developing A Unique & Trusted Industry Portal

GrowLife CEO Sterling Scott described his vision for Cannabis.org in a recent press release as “a living, evolving, multi-media, multi-subject offering that should truly encompass every significant facet of the culture and movement.” On a more practical level, the cannabis portal aims to provide a place for the cannabis movement to do everything from organize its political efforts to review various products and services that can help legal growers.

“It is important to note that this website joins our ever-growing portfolio of virtual and physical real estate in cannabis,” added Mr. Scott. “Over the last 18 months we have gone from a Company whose core was one of the most venerable and best selling home growing units in the business to a collection of quick growing retail brick-and-mortar stores, a network of revenue generating websites and now, a live website that we believe will soon be one of the most influential of its kind. Ultimately, we envision our collective assets heightening the efficacy of each sales channel through cross promotion and brand recognition.”

GrowLife to Debut Cannabis.org Marijuana Supersite October 1, 2013

WOODLAND HILLS, Calif., Sept. 23, 2013 /PRNewswire/ -- GrowLife, Inc. (PHOT), a provider of highly effective indoor growing technologies and unique lifestyle brands, is pleased to announce that the Company will go live with its much-anticipated Cannabis.org website, effective October 1, 2013. The site's launch will set in motion a progression intended to create the premier marijuana related web destination with information on all aspects of cannabis.

"We are pleased to at last release the first iteration of what we intend to develop into the premier cannabis/marijuana related web destination," stated Sterling Scott, CEO, GrowLife, Inc. "It has been a long time coming, due in no small part to the massive changes in the political climate over the past few weeks."

"On October 1, our investors and the cannabis community at large will have an opportunity to see the beginnings of this site's structure and purpose- a living, evolving, multi-media, multi-subject offering that should truly encompass every significant facet of the culture and movement," said Scott.

"It is important to note that this website joins our ever-growing portfolio of virtual and physical real estate in cannabis," added Scott. "Over the last 18 months we have gone from a Company whose core was one of the most venerable and best selling home growing units in the business to a collection of quick growing retail brick-and-mortar stores, a network of revenue generating websites and now, a live website that we believe will soon be one of the most influential of its kind. Ultimately, we envision our collective assets heightening the efficacy of each sales channel through cross promotion and brand recognition."